Abstract:Aims/hypothesis: Pancreatic beta cells secrete insulin to control glucose homeostasis. Beta cells can also adapt their function and mass when more insulin is required, especially in situations of insulin resistance (IR). Beta-cell mass adaptation can be achieved through either beta-cell proliferation or beta-cell neogenesis, a process that involves de novo beta-cell production from precursor cells. Signals and mechanisms that control adult beta-cell neogenesis and regulate the balance between beta-cell proliferation and/or beta-cell neogenesis still need to be fully deciphered. To do so, we previously developed a mouse model of pancreatic adaptation in response to a severe insulin resistance induced by a chronic glucocorticoid (GC) treatment. We observed a massive insulin production due to beta-cell adaptation by both proliferation and neogenesis. In the present study, we aimed at further characterizing beta-cell adaptation in response to mild or severe IR by studying various GC doses, along with other pharmacological or genetic models of IR. Further, we characterized the impact of aging on pancreatic adaptation in response to GC-induced IR. Finally, we precisely quantified adult beta-cell neogenesis by developing an original 3D method of beta-cell mass analysis in toto after organ clearing. Methods: Glucose metabolism, insulin secretion and pancreatic beta-cell adaptation were studied in mice rendered IR either by adipose tissue specific invalidation of SEIPIN, by chronic treatment with the insulin receptor antagonist S961 or by chronic treatment with several doses of GC both in young and aged mice. Moreover, we developed and used an unbiased- 3D analysis of beta cells on whole cleared pancreas. Results: We demonstrated that beta-cell neogenesis - reflected by an increase in islet density - is constantly observed in response to genetically- or pharmacology-induced (S961 or GC) IR. Next, we observed that pancreatic adaptation mechanisms are closely defined by the level of IR. Indeed, mild IR induced by low dose of GC resulted in functional adaptation solely, while more severe IR induced by higher doses of GC resulted in an increase in both islet density and mean islet size, reflecting beta-cell neogenesis and proliferation, respectively. Then, we showed that in older mice, beta-cell adaptation through neogenesis is preserved in response to IR. Finally, using a new and unbiased 3D analysis, we confirmed the increase in islet density and mean islet size after GCs treatment. Conclusions/interpretation: Our results present evidence that beta-cell neogenesis is a preferential mechanism of pancreatic adaptation to increase insulin secretion in response to IR in mice. Moreover, aging does not preclude beta-cell neogenesis, suggesting that it could be triggered in elderly to compensate for IR. Finally, our innovative technique of 3D analysis of whole pancreas confirms the existence of adult beta-cell neogenesis and offers a new avenue to study islet cells and pancreas adaptation.

Regulated and adaptive in vivo insulin secretion from islets only containing β-cells

In Vitro Expansion of Pancreatic Islet Clusters Facilitated by Hormones and Chemicals.

Systematic Single-Cell Analysis Provides New Insights into Heterogeneity and Plasticity of the Pancreas.

Heterogeneous Development of Β-Cell Populations in Diabetes-Resistant and Susceptible Mice

Reestablishment of Glucose Inhibition of Glucagon Secretion in Small Pseudoislets

Insulin regulates human pancreatic endocrine cell differentiation in vitro

Insulin resistance-driven beta-cell adaptation in mice: Mechanistic characterization and 3D analysis

Abnormal Regulation of Glucagon Secretion by Human Islet Alpha Cells in the Absence of Beta Cells

In Vivo And In Vitro Characterization Of Insulin-Producing Cells Obtained From Murine Bone Marrow

Cell identity dynamics and insight into insulin secretagogues when employing stem cell-derived islets for disease modeling

Evaluating insulin secretagogues in a humanized mouse model with functional human islets.

The future treatment for type 1 diabetes: Pig islet- or stem cell-derived β cells?

Pancreatic islet alpha cells regulate microtubule stability in neighboring beta cells to tune insulin secretion and induce functional heterogeneity in individual mouse and human islets

Paracrine regulation of insulin secretion

A δ-cell subpopulation with a pro-β-cell identity contributes to efficient age-independent recovery in a zebrafish model of diabetes

Pancreas-Specific Sirt1-Deficiency in Mice Compromises Beta-Cell Function Without Development of Hyperglycemia.

Resolving human α versus β cell fate allocation for the generation of stem cell-derived islets

Intra-islet glucagon signalling regulates beta-cell connectivity, first-phase insulin secretion and glucose homeostasis

Loss of electrical β-cell to δ-cell coupling underlies impaired hypoglycaemia-induced glucagon secretion in type-1 diabetes

Alpha-Cell Loss From Islet Impairs Its Insulin Secretion In Vitro And In Vivo

Delineating mouse β-cell identity during lifetime and in diabetes with a single cell atlas